Stryker Corp. announces plans to lay off 5 percent of its workforce, reducing operating cost by more than $100 million before the 2.3 percent med-tech levy takes effect in 2013.
Stryker Corp. (NYSE:SYK) officials said the company plans to cut 5 percent of its workforce over concerns about the impending 2.3 percent medical device tax prescribed by President Barack Obama's health care overhaul.
The Kalamazoo, Mich.-based orthopedic device giant expects layoffs and restructuring efforts to reduce costs by more than $100 million before the tax takes effect in 2013.
Officials said the reductions should free up capital for strategic investments and growth "despite the ongoing challenging economic environment and market slowdown in elective procedures." according to a press release. Restructuring efforts will cost the company an estimated $150 million to $175 million, much of which will be recorded in Q4 2011 earnings.
Stryker CEO Stephen MacMillan has long been a vocal critic of the device tax, telling an industry lobby conference in September, "There is no doubt that we're already starting to think about actions that offset that additional tax."
"Here we are, one of the greatest industries in the country, and we're staring down on January 1st, 2013 and the addition of a 2.3 percent excise tax, while meanwhile on the other side all the discussion in Washington is about creating jobs," he said.
MacMillan, who's on tap to take over as AdvaMed chairman next year, estimated the tab on the medical device tax at $150 million for Stryker.
Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-...
Reva Medical begins enrolling patients in Europe for a trial of its Fantom bioresorbable stent.
A subcommittee of the U.S. Senate's powerful Finance Committee holds a hearing on the medical device...
Zimmer Holdings and Biomet find a buyer for the knee and elbow assets they pledged to divest to...